Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefalium vs Tylenol for Migraine Attacks
NCT02582996Phase 3Suspended
- Sponsor
- Aché Laboratórios Farmacêuticos
- Start
- Apr 2020
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Cefalium in migraine, sponsored by Aché Laboratórios Farmacêuticos. Started Apr 2020; status: suspended.
02
Drugs
Cefalium
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02582996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02582996.